Glaukos Completes Patient Enrollment In Pivotal Phase Of U.S. IDE Clinical Trial For iStent SUPRA Post author:Sam Post published:February 15, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like PAREXEL Sold to Investment Firm in $5 Billion Deal June 19, 2017 Governor Launches $500 Million Initiative to Keep Massachusetts' Biotech World Booming June 19, 2017 <b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017
<b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017